Patrick Delavault
About
In The Last Decade
Patrick Delavault
14 papers receiving 1.2k citations
Hit Papers
Peers
Comparison fields: 5 of 90
- Genetics 715
- Molecular Biology 315
- Pulmonary and Respiratory Medicine 294
- Biomedical Engineering 258
- Biomaterials 242
Countries citing papers authored by Patrick Delavault
This map shows the geographic impact of Patrick Delavault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Delavault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Delavault more than expected).
Fields of papers citing papers by Patrick Delavault
This network shows the impact of papers produced by Patrick Delavault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Delavault. The network helps show where Patrick Delavault may publish in the future.
Co-authorship network of co-authors of Patrick Delavault
This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Delavault. A scholar is included among the top collaborators of Patrick Delavault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Delavault. Patrick Delavault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 18 | |
| 2 | 12 | |
| 3 | 2 | |
| 4 | 17 | |
| 5 | 87 | |
| 6 | 56 | |
| 7 | 1 | |
| 8 | 25 | |
| 9 | A phase 3 trial of local chemotherapy with biodegradable carmustine(BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma breakdown → | 980 |
| 10 | 67 | |
| 11 | 1 | |
| 12 | [Antibioprevention of recurrent cystitis. A randomized double-blind comparative trial of 2 dosages of pefloxacin]. | 9 |
| 13 | [Must pefloxacin and norfloxacin be studied separately against bacteria isolated from urinary tract infections by the API-ATB method?]. | 0 |
| 14 | [Acute cystitis in women over 50 years of age. Efficacy of pefloxacin with single dose and norfloxacin for 10 days]. | 7 |
| 15 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.